Alessandro Fatatis - Publications

Drexel University, Philadelphia, PA, United States 

58 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Worrede-Mahdi A, Meucci O, Fatatis A. Limiting tumor seeding as a therapeutic approach for metastatic disease. Pharmacology & Therapeutics. PMID 30877019 DOI: 10.1016/j.pharmthera.2019.03.007  0.84
2018 Qian C, Worrede-Mahdi A, Shen F, DiNatale A, Kaur R, Zhang Q, Cristofanilli M, Meucci O, Fatatis A. Impeding Circulating Tumor Cell Reseeding Decelerates Metastatic Progression and Potentiates Chemotherapy. Molecular Cancer Research : McR. PMID 30115759 DOI: 10.1158/1541-7786.MCR-18-0302  0.84
2016 Fatatis A, Shen F, Zhang Y, Jernigan DL, Feng X, Yan J, Garcia FU, Meucci O, Salvino JM. Novel Small-molecule CX3CR1 Antagonist Impairs Metastatic Seeding and Colonization of Breast Cancer Cells. Molecular Cancer Research : McR. PMID 27001765 DOI: 10.1158/1541-7786.MCR-16-0013  0.84
2015 Wurth R, Tarn K, Jernigan D, Fernandez SV, Cristofanilli M, Fatatis A, Meucci O. A Preclinical Model of Inflammatory Breast Cancer to Study the Involvement of CXCR4 and ACKR3 in the Metastatic Process. Translational Oncology. 8: 358-67. PMID 26500026 DOI: 10.1016/j.tranon.2015.07.002  1
2015 Talati PG, Gu L, Ellsworth EM, Girondo MA, Trerotola M, Hoang DT, Leiby B, Dagvadorj A, McCue PA, Lallas CD, Trabulsi EJ, Gomella L, Aplin AE, Languino L, Fatatis A, et al. Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer. The American Journal of Pathology. 185: 2505-22. PMID 26362718 DOI: 10.1016/j.ajpath.2015.04.026  1
2015 Gutierrez-Uzquiza A, Lopez-Haber C, Jernigan DL, Fatatis A, Kazanietz MG. PKCε Is an Essential Mediator of Prostate Cancer Bone Metastasis. Molecular Cancer Research : McR. 13: 1336-46. PMID 26023164 DOI: 10.1158/1541-7786.MCR-15-0111  1
2014 Sicoli D, Jiao X, Ju X, Velasco-Velazquez M, Ertel A, Addya S, Li Z, Andò S, Fatatis A, Paudyal B, Cristofanilli M, Thakur ML, Lisanti MP, Pestell RG. CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines. Cancer Research. 74: 7103-14. PMID 25452256 DOI: 10.1158/0008-5472.CAN-14-0612  1
2014 Fatatis A. Preface Signaling Pathways and Molecular Mediators in Metastasis. vii-viii. DOI: 10.1007/978-94-007-2558-4  1
2013 Caino MC, Chae YC, Vaira V, Ferrero S, Nosotti M, Martin NM, Weeraratna A, O'Connell M, Jernigan D, Fatatis A, Languino LR, Bosari S, Altieri DC. Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells. The Journal of Clinical Investigation. 123: 2907-20. PMID 23921130 DOI: 10.1172/JCI67841  1
2013 Trerotola M, Jernigan DL, Liu Q, Siddiqui J, Fatatis A, Languino LR. Trop-2 promotes prostate cancer metastasis by modulating β(1) integrin functions. Cancer Research. 73: 3155-67. PMID 23536555 DOI: 10.1158/0008-5472.CAN-12-3266  1
2013 Liu Q, Russell MR, Shahriari K, Jernigan DL, Lioni MI, Garcia FU, Fatatis A. Interleukin-1β promotes skeletal colonization and progression of metastatic prostate cancer cells with neuroendocrine features. Cancer Research. 73: 3297-305. PMID 23536554 DOI: 10.1158/0008-5472.CAN-12-3970  1
2013 Augello MA, Burd CJ, Birbe R, McNair C, Ertel A, Magee MS, Frigo DE, Wilder-Romans K, Shilkrut M, Han S, Jernigan DL, Dean JL, Fatatis A, McDonnell DP, Visakorpi T, et al. Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes. The Journal of Clinical Investigation. 123: 493-508. PMID 23257359 DOI: 10.1172/JCI64750  1
2012 Liu Q, Zhang Y, Jernigan D, Fatatis A. Survival and growth of prostate cancer cells in the bone: Role of the alpha-receptor for platelet-derived growth factor in supporting early metastatic foci Signaling Pathways and Molecular Mediators in Metastasis. 2147483647: 261-275. DOI: 10.1007/978-94-007-2558-4_11  1
2011 Jamieson-Gladney WL, Zhang Y, Fong AM, Meucci O, Fatatis A. The chemokine receptor CX₃CR1 is directly involved in the arrest of breast cancer cells to the skeleton. Breast Cancer Research : Bcr. 13: R91. PMID 21933397 DOI: 10.1186/bcr3016  1
2011 Liu Q, Jernigan D, Zhang Y, Fatatis A. Implication of platelet-derived growth factor receptor alpha in prostate cancer skeletal metastasis. Chinese Journal of Cancer. 30: 612-9. PMID 21880182 DOI: 10.5732/cjc.011.10225  1
2010 Russell MR, Liu Q, Fatatis A. Targeting the {alpha} receptor for platelet-derived growth factor as a primary or combination therapy in a preclinical model of prostate cancer skeletal metastasis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5002-10. PMID 20813817 DOI: 10.1158/1078-0432.CCR-10-1863  1
2010 Migneco G, Whitaker-Menezes D, Chiavarina B, Castello-Cros R, Pavlides S, Pestell RG, Fatatis A, Flomenberg N, Tsirigos A, Howell A, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling. Cell Cycle (Georgetown, Tex.). 9: 2412-22. PMID 20562527 DOI: 10.4161/cc.9.12.11989  1
2010 Bonuccelli G, Whitaker-Menezes D, Castello-Cros R, Pavlides S, Pestell RG, Fatatis A, Witkiewicz AK, Vander Heiden MG, Migneco G, Chiavarina B, Frank PG, Capozza F, Flomenberg N, Martinez-Outschoorn UE, Sotgia F, et al. The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts. Cell Cycle (Georgetown, Tex.). 9: 1960-71. PMID 20495363 DOI: 10.4161/cc.9.10.11601  1
2010 Russell MR, Liu Q, Lei H, Kazlauskas A, Fatatis A. The alpha-receptor for platelet-derived growth factor confers bone-metastatic potential to prostate cancer cells by ligand- and dimerization-independent mechanisms. Cancer Research. 70: 4195-203. PMID 20442296 DOI: 10.1158/0008-5472.CAN-09-4712  1
2010 Cook A, Hippensteel R, Shimizu S, Nicolai J, Fatatis A, Meucci O. Interactions between chemokines: regulation of fractalkine/CX3CL1 homeostasis by SDF/CXCL12 in cortical neurons. The Journal of Biological Chemistry. 285: 10563-71. PMID 20124406 DOI: 10.1074/jbc.M109.035477  1
2010 Fatatis A, D'Ambrosio JA, Jamieson WL, Jernigan DL, Russell MR. Microenvironment Factors Influencing Skeletal Metastases Tumor Microenvironment. 135-160. DOI: 10.1002/9780470669891.ch7  1
2009 D'Ambrosio J, Fatatis A. Osteoblasts modulate Ca2+ signaling in bone-metastatic prostate and breast cancer cells. Clinical & Experimental Metastasis. 26: 955-64. PMID 19768662 DOI: 10.1007/s10585-009-9286-3  1
2009 Russell MR, Jamieson WL, Dolloff NG, Fatatis A. The alpha-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells. Oncogene. 28: 412-21. PMID 18850002 DOI: 10.1038/onc.2008.390  1
2008 Jamieson WL, Shimizu S, D'Ambrosio JA, Meucci O, Fatatis A. CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism. Cancer Research. 68: 1715-22. PMID 18339851 DOI: 10.1158/0008-5472.CAN-07-1315  1
2007 Dolloff NG, Russell MR, Loizos N, Fatatis A. Human bone marrow activates the Akt pathway in metastatic prostate cells through transactivation of the alpha-platelet-derived growth factor receptor. Cancer Research. 67: 555-62. PMID 17234763 DOI: 10.1158/0008-5472.CAN-06-2593  1
2005 Dolloff NG, Shulby SS, Nelson AV, Stearns ME, Johannes GJ, Thomas JD, Meucci O, Fatatis A. Bone-metastatic potential of human prostate cancer cells correlates with Akt/PKB activation by alpha platelet-derived growth factor receptor. Oncogene. 24: 6848-54. PMID 16007172 DOI: 10.1038/sj.onc.1208815  1
2005 Khan MZ, Shimizu S, Patel JP, Nelson A, Le MT, Mullen-Przeworski A, Brandimarti R, Fatatis A, Meucci O. Regulation of neuronal P53 activity by CXCR 4. Molecular and Cellular Neurosciences. 30: 58-66. PMID 16005638 DOI: 10.1016/j.mcn.2005.05.007  1
2004 Khan MZ, Brandimarti R, Patel JP, Huynh N, Wang J, Huang Z, Fatatis A, Meucci O. Apoptotic and antiapoptotic effects of CXCR4: is it a matter of intrinsic efficacy? Implications for HIV neuropathogenesis. Aids Research and Human Retroviruses. 20: 1063-71. PMID 15585097 DOI: 10.1089/aid.2004.20.1063  1
2004 Shulby SA, Dolloff NG, Stearns ME, Meucci O, Fatatis A. CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Cancer Research. 64: 4693-8. PMID 15256432 DOI: 10.1158/0008-5472.CAN-03-3437  1
2004 Brandimarti R, Khan MZ, Fatatis A, Meucci O. Regulation of cell cycle proteins by chemokine receptors: A novel pathway in human immunodeficiency virus neuropathogenesis? Journal of Neurovirology. 10: 108-12. PMID 14982748 DOI: 10.1080/13550280490268287  1
2003 Khan MZ, Brandimarti R, Musser BJ, Resue DM, Fatatis A, Meucci O. The chemokine receptor CXCR4 regulates cell-cycle proteins in neurons. Journal of Neurovirology. 9: 300-14. PMID 12775414 DOI: 10.1080/13550280390201010  1
2000 Meucci O, Fatatis A, Simen AA, Miller RJ. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proceedings of the National Academy of Sciences of the United States of America. 97: 8075-80. PMID 10869418 DOI: 10.1073/pnas.090017497  1
1999 Fatatis A, Miller RJ. Cell cycle control of PDGF-induced Ca(2+) signaling through modulation of sphingolipid metabolism. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 13: 1291-301. PMID 10428754  1
1998 Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 95: 14500-5. PMID 9826729 DOI: 10.1073/pnas.95.24.14500  1
1997 Moss J, Yuan CS, Fatatis A, Attele A. Effects of histamine on intracellular calcium transients recorded with Fura-2 in renal pacemaker cells in guinea pig. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 46: S95-6. PMID 9098783  1
1997 Fatatis A, Miller RJ. Platelet-derived growth factor (PDGF)-induced Ca2+ signaling in the CG4 oligodendroglial cell line and in transformed oligodendrocytes expressing the beta-PDGF receptor. The Journal of Biological Chemistry. 272: 4351-8. PMID 9020156 DOI: 10.1074/jbc.272.7.4351  1
1996 Meucci O, Fatatis A, Holzwarth JA, Miller RJ. Developmental regulation of the toxin sensitivity of Ca(2+)-permeable AMPA receptors in cortical glia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 519-30. PMID 8551336  1
1996 Fatatis A, Miller RJ. Sphingosine and sphingosine 1-phosphate differentially modulate platelet-derived growth factor-BB-induced Ca2+ signaling in transformed oligodendrocytes. The Journal of Biological Chemistry. 271: 295-301. PMID 8550576  1
1995 Di Renzo G, Amoroso S, Bassi A, Fatatis A, Cataldi M, Colao AM, Lombardi G, Annunziato L. Role of the Na(+)-Ca2+ and Na(+)-H+ antiporters in prolactin release from anterior pituitary cells in primary culture. European Journal of Pharmacology. 294: 11-5. PMID 8788411 DOI: 10.1016/0014-2999(95)00505-6  1
1994 Fatatis A, Holtzclaw LA, Avidor R, Brenneman DE, Russell JT. Vasoactive intestinal peptide increases intracellular calcium in astroglia: synergism with alpha-adrenergic receptors. Proceedings of the National Academy of Sciences of the United States of America. 91: 2036-40. PMID 8134346  1
1994 Fatatis A, Caporaso R, Iannotti E, Bassi A, Di Renzo G, Annunziato L. Relationship between time of activation of phospholipase C-linked plasma membrane receptors and reloading of intracellular Ca2+ stores in LAN-1 human neuroblastoma cells. The Journal of Biological Chemistry. 269: 18021-7. PMID 8027061  1
1994 Fatatis A, Bassi A, Iannotti E, Caso N, Mita GD, Di Renzo G, Annunziato L. Appearance of depolarization- and maitotoxin-induced [Ca2+]i elevation in single LAN-1 human neuroblastoma cells on exposure to retinoic acid. Journal of Neurochemistry. 63: 1900-7. PMID 7523602 DOI: 10.1046/j.1471-4159.1994.63051900.x  1
1993 Russo T, Mogavero AR, Ammendola R, Mesuraca M, Fiore F, Fatatis A, Salvatore G, Cimino F. Immortalization of a cell line showing some characteristics of the oligodendrocyte phenotype. Neuroscience Letters. 159: 159-62. PMID 8264960 DOI: 10.1016/0304-3940(93)90823-4  1
1992 Fatatis A, Holtzclaw L, Payza K, Russell JT. Secretion from rat neurohypophysial nerve terminals (neurosecretosomes) rapidly inactivates despite continued elevation of intracellular Ca2+. Brain Research. 574: 33-41. PMID 1638405 DOI: 10.1016/0006-8993(92)90796-C  1
1992 Annunziato L, Taglialatela M, Canzoniero LM, Fatatis A, Di Rienzo G. The Na(+)-Ca++ exchanger in central nerve endings: the relationship between its pharmacological blockade and dopamine release from tuberoinfundibular hypothalamic neurons. Neurochemistry International. 20: 95S-99S. PMID 1365465 DOI: 10.1016/0197-0186(92)90218-G  1
1992 Fatatis A, Russell JT. Spontaneous changes in intracellular calcium concentration in type I astrocytes from rat cerebral cortex in primary culture. Glia. 5: 95-104. PMID 1349589 DOI: 10.1002/glia.440050203  1
1992 Savarese DM, Russell JT, Fatatis A, Liotta LA. Type IV collagen stimulates an increase in intracellular calcium. Potential role in tumor cell motility. The Journal of Biological Chemistry. 267: 21928-35. PMID 1328249  1
1992 Fatatis A, Bassi A, Mita G, Di Renzo GF, Annunziato L. LAN-1 human neuroblastoma cells are provided of endothelin-1 receptors linked to [Ca++]i elevation. Functional Neurology. 7: 239-42. PMID 1323509  1
1992 Fatatis A, Bassi A, Monsurrò MR, Sorrentino G, Mita GD, Di Renzo GF, Annunziato L. LAN-1: a human neuroblastoma cell line with M1 and M3 muscarinic receptor subtypes coupled to intracellular Ca2+ elevation and lacking Ca2+ channels activated by membrane depolarization. Journal of Neurochemistry. 59: 1-9. PMID 1319463  1
1992 Fatatis A, Bassi A, Di Renzo GF, Annunziato L. LAN-1 human neuroblastoma cells become responsive to membrane depolarization and maitotoxin induced [Ca++]i increase after retinoic acid-induced differentiation Pharmacological Research. 26: 25.  1
1992 Annunziato L, Fatatis A, Bassi A. Regulation of intracellular Ca++ homeostasis in single LAN-1 neuroblastoma cells by multiple phosphoinositide linked receptors Pharmacological Research. 26: 102.  1
1991 Di Renzo G, Galbiati E, Taglialatela M, Fatatis A, Canzoniero L, Annunziato L. A pharmacological study on the possible mechanisms underlying changes in TSH secretion in aged male rats Neuroendocrinology Letters. 13: 377-385.  1
1990 Taglialatela M, Canzoniero LM, Fatatis A, Di Renzo G, Yasumoto T, Annunziato L. Effect of maitotoxin on cytosolic Ca2+ levels and membrane potential in purified rat brain synaptosomes. Biochimica Et Biophysica Acta. 1026: 126-32. PMID 2378876 DOI: 10.1016/0005-2736(90)90342-L  1
1990 Annunziato L, Canzoniero LMT, Fatatis A, Taglialatela M, Di Renzo G. The inhibition of the Na+-Ca++ antiporter by amiloride analogues can modulate dopamine release from tuberoinfundibular hypothalamic neurons European Journal of Pharmacology. 183: 257. DOI: 10.1016/0014-2999(90)93106-Z  1
1990 Di Renzo G, Taglialatela M, Canzoniero L, Fatatis A. Lack of evidence for an involvement of adenosine receptors in the control of TSH secretion in the rat Neuroendocrinology Letters. 12: 113-119.  1
1989 Taglialatela M, Canzoniero LM, Amoroso S, Fatatis A, Di Renzo GF, Annunziato L. Cobalt-sensitive and dihydropyridine-insensitive stimulation of dopamine release from tuberoinfundibular neurons by high extracellular concentrations of barium ions. Brain Research. 488: 114-20. PMID 2743107 DOI: 10.1016/0006-8993(89)90699-9  1
1989 Di Renzo G, Amoroso S, Taglialatela M, Canzoniero L, Basile V, Fatatis A, Annunziato L. Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion. European Journal of Pharmacology. 162: 371-3. PMID 2524399 DOI: 10.1016/0014-2999(89)90302-6  1
1988 Taglialatela M, Amoroso S, Canzoniero LMT, Fatatis A, Di Renzo SF, Annunziato L. Characterization of the membrane Ca++-transporting systems in striatal synaptosomes Pharmacological Research Communications. 20: 377.  1
Show low-probability matches.